Accès gratuit
Numéro |
Biologie Aujourd'hui
Volume 204, Numéro 1, 2010
|
|
---|---|---|
Page(s) | 71 - 80 | |
Section | L'immunothérapie passive aujourd'hui | |
DOI | https://doi.org/10.1051/jbio/2009049 | |
Publié en ligne | 8 avril 2010 |
- Anderson D.C., WHO guidelines dealing with immunoglobulin use impede rabies prevention. Asian Biomedicine, 2007, 1, 103-107. [Google Scholar]
- Anderson G.R., Sgouris J.T., The preparation of rabies immune globulin and use in monkeys following virus challenge, Symposia Series in Immunobiological Standardization, T. International Symposium on Rabies (Ed.), 1965, Karger, Basel, p. 319. [Google Scholar]
- Anonymous., WHO Expert Consultation on rabies. In World Health Organ Tech Rep Ser, WHO, 2005, Geneva, pp. 1-88. [Google Scholar]
- Archer B.G., Dierks R.E., Effects of homologous or heterologous antiserum on neutralizing-antibody response to rabies vaccine. Bull World Health Organ, 1968, 39, 407-417. [PubMed] [Google Scholar]
- Atanasiu P., Bahmanyar M., Baltazard M., Fox J.P., Habel K., Kaplan M.M., Kissling R.E., Komarov A., Koprowski H., Lépine P., Perez Gallardo F., Schaeffer M., Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. 1. Bull World Health Organ, 1956, 14, 593-611. [PubMed] [Google Scholar]
- Atanasiu P., Bahmanyar M., Baltazard M., Fox J.P., Habel K., Kaplan M.M., Kissling R.E., Komarov A., Koprowski H., Lépine P., Perez Gallardo F., Schaeffer M., Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. 2. Bull World Health Organ, 1957, 17, 911-932. [PubMed] [Google Scholar]
- Atanasiu P., Cannon D.A., Dean D.J., Fox J.P., Habel K., Kaplan M.M., Kissling R.E., Koprowski H., Lépine P., Perez Gallardo F., Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. 3. Bull World Health Organ, 1961, 25, 103-114. [PubMed] [Google Scholar]
- Atanasiu P., Dean D.J., Habel K., Kaplan M.M., Koprowski H., Lépine P., Serie C., Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. 4. Bull World Health Organ, 1967, 36, 361-365. [PubMed] [Google Scholar]
- Babes V., Lepp M., Recherches sur la vaccination antirabique. Ann Inst Pasteur (Paris), 1889, 3, 385-390. [Google Scholar]
- Babes V., Cherchez T., Expérience sur l'atténuation du virus fixe. Ann Inst Pasteur (Paris), 1891, 10, 625-632. [Google Scholar]
- Badrane H., Bahloul C., Perrin P., Tordo N., Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity. J Virol, 2001, 75, 3268-3276. [CrossRef] [PubMed] [Google Scholar]
- Bahmanyar M., Results of rabies post-exposure treatment with antirabies serum and the human diploid cell vaccine in Iran. Dev Biol Stand, 1978, 40, 163-165. [PubMed] [Google Scholar]
- Bahmanyar M., Fayaz A., Nour-Salehi S., Mohammadi M., Koprowski H., Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum. J Am Med Assoc, 1976, 236, 2751-2754. [CrossRef] [PubMed] [Google Scholar]
- Bahmanyar M., Fayaz A., Nour-Salehi S., Mohammadi M., Koprowski H., Successful protection of humans expo-sed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antira-bies serum. Wilderness Environ Med, 2000, 11, 42-46. [PubMed] [Google Scholar]
- Bakker A.B., Marissen W.E., Kramer R.A., Rice A.B., Weldon W.C., Niezgoda M., Hanlon C.A., Thijsse S., Backus H.H., de Kruif J., Dietzschold B., Rupprecht C.E., Goudsmit J., Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants. J Virol, 2005, 79, 9062-9068. [CrossRef] [PubMed] [Google Scholar]
- Bakker A.B., Python C., Kissling C.J., Pandya P., Marissen W.E., Brink M. F., Lagerwerf F., Worst S., van Corven E., Kostense S., Hartmann K., Weverling G.J., Uytdehaag F., Herzog C., Briggs D.J., Rupprecht C.E., Grimaldi R., Goudsmit J., First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity. Vaccine, 2008, 26, 5922-5927. [CrossRef] [PubMed] [Google Scholar]
- Baltazard M., Bahmanyar M., Field trials with rabies vaccine on persons bitten by rabid wolves. Bull World Health Organ, 1955, 13, 747-772. [PubMed] [Google Scholar]
- Benmansour A., Leblois H., Coulon P., Tuffereau C., Gaudin Y., Flamand A., Lafay F., Antigenicity of rabies virus glycoprotein. J Virol, 1991, 65, 4198-4203. [PubMed] [Google Scholar]
- Bourhy H., Dacheux L., Strady C., Mailles A., Rabies in Europe in 2005. Euro Surveill, 2005, 10, 213-216. [PubMed] [Google Scholar]
- Bourhy H., Goudal M., Mailles A., Sadkowska-Todys M., Dacheux L., Zeller H., Is there a need for anti-rabies vaccine and immunoglobulins rationing in Europe? Euro Surveill, 2009, 14. [Google Scholar]
- Cabasso V.J., Properties of rabies immune globulin of human origin. J Biol Stand, 1974, 2, 43-50. [CrossRef] [PubMed] [Google Scholar]
- Cabasso V.J., Dobkin M.B., Roby R.E., Hammar A.H., Antibody response to a human diploid cell rabies vaccine. Appl Microbiol, 1974, 27, 553-561. [PubMed] [Google Scholar]
- Cabasso V.J., Loofbourow J.C., Roby R.E., Anuskiewicz W., Rabies immune globulin of human origin: preparation and dosage determination in non-exposed volunteer subjects. Bull World Health Organ, 1971, 45, 303-315. [PubMed] [Google Scholar]
- Champion J.M., Kean R.B., Rupprecht C.E., Notkins A.L., Koprowski H., Dietzschold B., Hooper D.C., The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure. J Immunol Methods, 2000, 235, 81-90. [CrossRef] [PubMed] [Google Scholar]
- Coutard B., Gorbalenya A.E., Snijder E.J., Leontovich A.M., Poupon A., de Lamballerie X., Charrel R., Gould E.A., Gunther S., Norder H., Klempa B., Bourhy H., Rohayem J., L'Hermite E., Nordlund P., Stuart D.I., Owens R.J., Grimes J.M., Tucker P.A., Bolognesi M., Mattevi A., Coll M., Jones T.A., Aqvist J., Unge T., Hilgenfeld R., Bricogne G., Neyts J., La Colla P., Puerstinger G., Gonzalez J.P., Leroy E., Cambillau C., Romette J.L., Canard B., The VIZIER project: preparedness against pathogenic RNA viruses. Antiviral Res, 2008, 78, 37-46. [CrossRef] [PubMed] [Google Scholar]
- Cupo P., Azedevo-Marques M.M., Sarti W., Hering S.E., Proposal of abolition of the skin sensitivity test before equine rabies immune globulin application. Rev Inst Med Trop Sao Paulo, 2001, 43, 51-53. [PubMed] [Google Scholar]
- Dacheux L., Reynes J.M., Buchy P., Sivuth O., Diop B.M., Rousset D., Rathat C., Jolly N., Dufourcq J.B., Nareth C., Diop S., Iehle C., Rajerison R., Sadorge C., Bourhy H., A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clin Infect Dis, 2008, 47, 1410-1417. [Google Scholar]
- de Kruif J., Bakker A.B., Marissen W.E., Kramer R.A., Throsby M., Rupprecht C.E., Goudsmit J., A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis. Annu Rev Med, 2007, 58, 359-568. [CrossRef] [PubMed] [Google Scholar]
- Dean D., Local wound treatment of animal bites, Proc. Nat. Rabies Symposium, Nat. Commun. Dis. Center, 1966, Atlanta, Georgia, p. 85. [Google Scholar]
- Dean D.J., Baer G.M., Thompson W.R., Studies on the local treatment of rabies-infected wounds. Bull World Health Organ, 1963, 28, 477-486. [PubMed] [Google Scholar]
- Delmas O., Holmes E.C., Talbi C., Larrous F., Dacheux L., Bouchier C., Bourhy H., Genomic diversity and evolution of the lyssaviruses. PLoS ONE, 2008, 3, e2057. [Google Scholar]
- Dietzschold B., Gore M., Casali P., Ueki Y., Rupprecht C.E., Notkins A.L., Koprowski H., Biological characterization of human monoclonal antibodies to rabies virus. J Virol, 1990, 64, 3087-3090. [PubMed] [Google Scholar]
- Dietzschold B., Tollis M., Lafon M., Wunner W.H., Koprowski H., Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies. Virology, 1987, 161, 29-36. [CrossRef] [PubMed] [Google Scholar]
- Dodet B., Adjogoua E.V., Aguemon A.R., Amadou O.H., Atipo A.L., Baba B.A., Ada S.B., Boumandouki P., Bourhy H., Diallo M.K., Diarra L., Diop B. M., Diop S.A., Fesriry B., Gosseye S., Hassar M., Kinge T., Kombila Nzamba T.E., Yandoko E.N., Nzengue E., Ramahefalalao E.F., 2nd, Ratsitorahina M., Simpore L., Soufi A., Tejiokem M., Thiombano R., Tiembre I., Traore A.K., Wateba M.I., Fighting rabies in Africa: the Africa Rabies Expert Bureau (AfroREB). Vaccine, 2008a, 26, 6295-6298. [CrossRef] [PubMed] [Google Scholar]
- Dodet B., Goswami A., Gunasekera A., de Guzman F., Jamali S., Montalban C., Purba W., Quiambao B., Salahuddin N., Sampath G., Tang Q., Tantawichien T., Wimalaratne O., Ziauddin A., Rabies awareness in eight Asian countries. Vaccine, 2008b, 26, 6344-6348. [CrossRef] [PubMed] [Google Scholar]
- Dorfman N., Dietzschold B., Kajiyama W., Fu Z.F., Koprowski H., Notkins A.L., Development of human monoclonal antibodies to rabies. Hybridoma, 1994, 13, 397-402. [CrossRef] [PubMed] [Google Scholar]
- Fernandes A., Kaundinya J.O., Daftary G., Saxena L., Banerjee S., Pattnaik P., Chromatographic purification of equine immunoglobulin G F(ab)2 from plasma. J Chromatogr B Analyt Technol Biomed Life Sci, 2008, 876, 109-115. [CrossRef] [PubMed] [Google Scholar]
- Folb J.E., Cooke R.P., Issues of human rabies immunoglobulin and vaccine: policy versus practice. J Public Health (Oxf), 2007, 29, 83-87. [CrossRef] [PubMed] [Google Scholar]
- Gautret P., Soula G., Adamou H., Soavi M.J., Delmont J., Rotivel Y., Parola P., Brouqui P., Rabies postexposure prophylaxis, Marseille, France, 1994-2005. Emerg Infect Dis, 2008, 14, 1452-1454. [CrossRef] [PubMed] [Google Scholar]
- Glück R., Labert D., Techniques de purification de l'immunsérum antirabique hétérologue. La rage: techniques de laboratoire, Meslin F.-X, Kaplan M.M.,. Koprowski H (Eds.), 1999, Organisation Mondiale de la Santé, Genève, pp. 411-416. [Google Scholar]
- Goudsmit J., Marissen W.E., Weldon W.C., Niezgoda M., Hanlon C.A., Rice A.B., Kruif J., Dietzschold B., Bakker A.B., Rupprecht C.E., Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin. J Infect Dis, 2006, 193, 796-801. [CrossRef] [PubMed] [Google Scholar]
- Habel K., Seroprophylaxis in experimental rabies. Pub Hlth Rep, 1945, 60, 545. [Google Scholar]
- Hanlon C.A., Kuzmin I.V., Blanton J.D., Weldon W.C., Manangan J.S., Rupprecht C.E., Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Res, 2005, 111, 44-54. [CrossRef] [PubMed] [Google Scholar]
- Hattwick M.A.W., Rubin R.H., Music S., Sikes R.K., Smith J.S., Gregg M. D., Postexposure rabies prophylaxis with human rabies immune globulin. J Am Med Assoc, 1974, 227, 407. [CrossRef] [PubMed] [Google Scholar]
- Helmick C.G., Johnstone C., Sumner J., Winkler W.G., Fager S., A clinical study of Merieux human rabies immune globulin. J Biol Stand, 1982, 10, 357-367. [CrossRef] [PubMed] [Google Scholar]
- Hosty T.S., Kissling R.E., Schaeffer M., Wallace G.A., Dibble E.H., Human antirabies gamma globulin. Bull World Health Organ, 1959, 20, 1111-1119. [PubMed] [Google Scholar]
- Kaplan M.M., Cohen D., Koprowski H., Dean D., Ferrigan, L., Studies on the local treatment of wounds for the prevention of rabies. Bull World Health Organ, 1962, 26, 765-775. [PubMed] [Google Scholar]
- Kaplan M.M., Paccaud M.F., Effectiveness of locally inoculated antirabies serum and gamma-globulin in rabies infection of mice. Bull World Health Organ, 1963, 28, 495-497. [PubMed] [Google Scholar]
- Karliner J.S., Belaval G.S., Incidence of reactions following administration of antirabies serum; study of 526 cases. J Amer Med Assoc, 1965, 193, 359-362. [Google Scholar]
- Knobel D.L., Cleaveland S., Coleman P.G., Fevre E.M., Meltzer M.I., Miranda M.E., Shaw A., Zinsstag J., Meslin F.X., Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ, 2005, 83, 360-368. [PubMed] [Google Scholar]
- Koprowski H., Van der Scheer J., Black J., Use of hyperimmune antirabies serum concentrates in experimental animals. Am J Med, 1950, 8, 412. [CrossRef] [PubMed] [Google Scholar]
- Kuzmin I.V., Wu X., Tordo N., Rupprecht C.E., Complete genomes of Aravan, Khujand, Irkut and West Caucasian bat viruses, with special attention to the polymerase gene and non-coding regions. Virus Res, 2008,136, 81-90. [Google Scholar]
- Lafon M., Edelman L., Bouvet J.P., Lafage M., Montchatre E., Human monoclonal antibodies specific for the rabies virus glycoprotein and N protein. J Gen Virol, 1990, 71, 1689-1696. [CrossRef] [PubMed] [Google Scholar]
- Lang J., Attanath P., Quiambao B., Singhasivanon V., Chanthavanich P., Montalban C., Lutsch C., Pepin-Covatta S., Le Mener V., Miranda M., Sabchareon A., Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine. Acta Trop, 1998, 70, 313-333. [Google Scholar]
- Luekrajang T., Wangsai J., Phanuphak P., Production de sérum antirabique d'origine équine, La rage: techniques de laboratoire, Meslin F.-X., Kaplan M.M., Koprowski H. (Eds.), 1999, Organisation Mondiale de la Santé, Genève, pp. 407-410. [Google Scholar]
- Marie A., Recherches sur le sérum antirabique. Ann Inst Pasteur (Paris), 1908, 22, 271. [Google Scholar]
- Marissen W.E., Kramer R.A., Rice A., Weldon W.C., Niezgoda M., Faber M., Slootstra J.W., Meloen R.H., Clijsters-van der Horst M., Visser T.J., Jongeneelen M., Thijsse S., Throsby M., de Kruif J., Rupprecht C.E., Dietzschold B., Goudsmit J., Bakker A.B., Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis. J Virol, 2005, 79, 4672-4678. [CrossRef] [PubMed] [Google Scholar]
- Muhamuda K., Madhusudana S.N., Ravi V., Use of neutralizing murine monoclonal antibodies to rabies glycoprotein in passive immunotherapy against rabies. Hum Vaccin, 2007, 3, 192-195. [PubMed] [Google Scholar]
- OMS, Comité d'expert de la rage. G. (Ed.), Série de rapports techniques. Deuxième rapport, Organisation Mondiale de la Santé, Genève, 1954. [Google Scholar]
- Proca G., Bobes S., Immunisation contre la rage: vaccins vivants et vaccins tués. Bull Org Hyg SDN, 1940, 9, 85-137. [Google Scholar]
- Prosniak M., Faber M., Hanlon C.A., Rupprecht C.E., Hooper D.C., Dietzschold B. Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies. J Infect Dis, 2003,188, 53-56. [Google Scholar]
- Quiambao B.P., Dytioco H.Z., Dizon R.M., Crisostomo M.E., Laot T.M., Teuwen D.E., Rabies post-exposure prophylaxis in the Philippines: health status of patients having received purified equine F(ab')(2) fragment rabies immunoglobulin (Favirab). PLoS Negl Trop Dis, 2008, 2, e243. [Google Scholar]
- Saesow N., Chaiwatanarat T., Mitmoonpitak C., Wilde H., Diffusion and fate of intramuscularly injected human rabies immune globulin. Acta Trop, 2000, 76, 289-292. [CrossRef] [PubMed] [Google Scholar]
- Schumacher C.L., Dietzschold B., Ertl H.C., Niu H.S., Rupprecht C.E., Koprowski H., Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies. J Clin Invest, 1989, 84, 971-975. [CrossRef] [PubMed] [Google Scholar]
- Schumacher C.L., Ertl H.C., Koprowski H., Dietzschold B., Inhibition of immune responses against rabies virus by monoclonal antibodies directed against rabies virus antigens. Vaccine, 1992, 10, 754-760. [CrossRef] [PubMed] [Google Scholar]
- Selimov M., Boltucij L., Semenova E., Kobrinskij G., Zmusko L., Results of the use of antirabies gamma glubulin and vaccine in prophylaxis of rabies in the Soviet Union. J Hyg Epidem Microbiol Immunol (Praha), 1959, 3, 168. [Google Scholar]
- Sikes R.K., Human rabies immune globulin. Public Health Rep, 1969, 84, 797-801. [PubMed] [Google Scholar]
- Sloan S.E., Hanlon C., Weldon W., Niezgoda M., Blanton J., Self J., Rowley K.J., Mandell R.B., Babcock G.J., Thomas W.D. Jr., Rupprecht C.E., Ambrosino D.M., Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates. Vaccine, 2007, 25, 2800-2810. [CrossRef] [PubMed] [Google Scholar]
- Suwansrinon, K., Jaijareonsup W., Wilde H., Benjavongkulchai M., Sriaroon C., Sitprija V., Sex- and age-related differences in rabies immunoglobulin hypersensitivity. Trans R Soc Trop Med Hyg, 2007, 101, 206-208. [CrossRef] [PubMed] [Google Scholar]
- Suwansrinon K., Jaijaroensup W., Daviratanasilpa S., Sriaroon C., Wilde H., Sitprija V. Adverse reactions to human rabies immune globulin manufactured by the Thai Red Cross Society. Vaccine, 2005, 23, 1324-1325. [CrossRef] [PubMed] [Google Scholar]
- WHO, Comité d'experts de la rage, G. (Ed.), Série de rapports techniques. Premier rapport, Organisation Mondiale de la Santé, Genève, 1950. [Google Scholar]
- WHO, Who Expert Committee on Rabies, G. (Ed.) Who Technical Report Series. Sixth Report, World Health Organization, Genève, 1973. [Google Scholar]
- WHO, Rabies vaccine. Position paper. Wkly Epidemiol Rec, 2007, 425-435. [Google Scholar]
- Wiktor T.J., Lerner R.A., Koprowski H., Inhibitory effect of passive antibody on active immunity induced against rabies by vaccination. Bull World Health Organ, 1971, 45, 747-753. [PubMed] [Google Scholar]
- Wilde H., Failures of post-exposure rabies prophylaxis. Vaccine, 2007, 25, 7605-7609. [CrossRef] [PubMed] [Google Scholar]
- Willoughby R.E.Jr., Tieves K.S., Hoffman G.M., Ghanayem N.S., Amlie-Lefond C.M., Schwabe M.J., Chusid M.J., Rupprecht C.E., Survival after treatment of rabies with induction of coma. N Engl J Med, 2005, 352, 2508-2514. [CrossRef] [PubMed] [Google Scholar]
- Winkler W.G., Schmidt R.C., Sikes R.K. Evaluation of human rabies immune globulin and homologous and heterologous antibody. J Immunol, 1969, 102, 1314-1321. [PubMed] [Google Scholar]
- Zhao X.L., Yin J., Chen W.Q., Jiang M., Yang G., Yang Z.H., Generation and characterization of human monoclonal antibodies to G5, a linear neutralization epitope on glycoprotein of rabies virus, by phage display technology. Microbiol Immunol, 2008, 52, 89-93. [CrossRef] [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.